ironSource (NYSE:IS) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 50 percent. This is unchanged from the same period last year. The company reported quarterly sales of $183.78 million which beat the analyst consensus estimate of $183.33 million by 0.25 percent. This is a 36.10 percent increase over sales of $135.04 million the same period last year.
TFF Pharmaceuticals Enters Into CRADA With The U.S. Army And The Geneva Foundation To Develop Dry Powder Needle-free Medical Countermeasures; Terms Not Disclosed
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technologyTFF Pharmaceuticals, Inc. (NASDAQ:TFFP
